Advertisement

Rheumatology International

, Volume 10, Issue 4, pp 171–175 | Cite as

HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients

  • B. Lang
  • I. Melchers
  • A. Urlacher
  • R. F. Tanzi-Fetta
  • S. Kohlbrenner
  • M. M. Tongio
  • H. H. Peter
Article

Summary

This study of 110 seropositive rheumatoid arthritis (RA) patients confirms the significant association of susceptibility to RA with HLA-DR4 specificity (P<0.001). The DR1 frequency is elevated in the entire seropositive patient group, reaching marginal significance (P<0.025). The DR4-negative patients, however, have a much higher prevalence of DR1 (P<0.001). Surprisingly, the DRw6 specificity is significantly increased in the remaining DR4- and DR1-negative patients (P<0.01). These results demonstrate that RA is not associated with a single HLA-specificity, but to various degrees with DR4, DR1, and DRw6. These findings, and particularly the newly recognized association with DRw6, support the hypothesis that functionally equivalent shared epitopes or conformations on otherwise distinct MHC molecules may confer risk for developing RA.

Key words

Rheumatoid arthritis HLA-DR antigens Conformational equivalence hypothesis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kaufman JF, Andersen RL, Strominger JL (1980) HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis. J Exp Med 152: 37–53Google Scholar
  2. 2.
    Kaufman JF, Auffray C, Korman AJ, Schackelford DA, Strominger J (1984) The class II molecules of the human and murine major histocompatibility complex. Cell 36: 1–13CrossRefPubMedGoogle Scholar
  3. 3.
    Bohme J, Andersson M, Andersson G, Moller E, Peterson PA, Rask L (1985) HLA-DRβ genes vary in number between different DR specificities, whereas the number of DQβ genes is constant. J Immunol 135: 2149–2155PubMedGoogle Scholar
  4. 4.
    Spies T, Sorrentino R, Boss JM, Okada K, Strominger JL (1985) Structural organization of the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci USA 82: 5165–5169PubMedGoogle Scholar
  5. 5.
    Korman AJ, Boss JM, Spies T, Sorrentino R, Okada K, Strominger JL (1985) Genetic complexity and expression of human class II histocompatibility genes. Immunol Rev 85: 45–86PubMedGoogle Scholar
  6. 6.
    Schwartz RH (1985) T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 3: 237–261CrossRefPubMedGoogle Scholar
  7. 7.
    Gibofsky A, Winchester RJ, Patarroyo M, Fotino M, Kunkel HG (1978) Disease associations of the Ia-like human alloantigens. J Exp Med 148: 1728–1732CrossRefPubMedGoogle Scholar
  8. 8.
    Stastny P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298: 869–871PubMedGoogle Scholar
  9. 9.
    Stastny P (1980) Joint report: rheumatoid arthritis. In: Terasaki PI (ed) Histocompatibility testing 1980. UCLA, Los Angeles, pp 681–686Google Scholar
  10. 10.
    Husby G, Gran JT, Ostensen M, Johannessen A, Thorsby E (1979) HLA-DRw4 and rheumatoid arthritis. Lancet I: 548–549Google Scholar
  11. 11.
    McMichael AJ, Sasazuki T, McDevitt HO, Payne RO (1977) Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum 20: 1037–1041PubMedGoogle Scholar
  12. 12.
    Legrand L, Lathrop GM, Marcelli-Barge A, Dryll A, Bardin T, Debeyre N, Poirier JC, Schmid M, Ryckewaert A, Dausset J (1984) HLA-DR genotype risks in seropositive rheumatoid arthritis. Am J Hum Genet 36: 690–699PubMedGoogle Scholar
  13. 13.
    Jaraquemada D, Ollier W, Awad J, Young A, Silman A, Roitt IM, Corbett M, Hay F, Cosh JA, Maini RN (1986) HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 45: 627–636PubMedGoogle Scholar
  14. 14.
    Swiss Federal Commission for the Rheumatic Diseases (1986) HLA-DR antigens in rheumatoid arthritis. A Swiss collaborative study; final report. Rheumatol Int 6: 89–92Google Scholar
  15. 15.
    Alarcon GS, Koopman WJ, Acton RT, Barger BO (1983) DR antigen distribution in Blacks with rheumatoid arthritis. J Rheumatol 10: 579–583PubMedGoogle Scholar
  16. 16.
    Ollier W, Carthy D, Cutbush S, Okoye R, Awad J, Fielder A, Silman A, Festenstein H (1989) HLA-DR4 associated Dw types in rheumatoid arthritis. Tissue Antigens 33: 30–37PubMedGoogle Scholar
  17. 17.
    Maeda H, Juji T, Mitsui H, Sonozaki H, Okitsu K (1981) HLA DR4 and rheumatoid arthritis in Japanese people. Ann Rheum Dis 40: 299–302PubMedGoogle Scholar
  18. 18.
    Ohata N, Nishimura YK, Tanimoto K, Horiuchi Y, Abe C, Shiokawa Y, Abe T, Katagiri M, Yoshiki T, Sasazuki T (1982) Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol 5: 123–127Google Scholar
  19. 19.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324PubMedGoogle Scholar
  20. 20.
    Terasaki PI (1965) Microdroplet assay for human blood lymphotoxins. In: Amos DB, van Rood JJ (eds) Histocompatibility testing. National Academy of Sciences, Washington DC, p 171Google Scholar
  21. 21.
    Woolf B (1955) On estimating the relation between blood groups and disease. Ann Hum Genet 19: 251–253PubMedGoogle Scholar
  22. 22.
    Gregersen PK, Shen M, Song Q, Merryman P, Degar S, Seki T, Maccari J, Goldberg D, Murphy H, Schwenzer J, Wang CY, Winchester RJ, Nepom GT, Silver J (1986) Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci USA 83: 2642–2646PubMedGoogle Scholar
  23. 23.
    Lang B, Navarrete C, LoGalbo PR, Nepom GT, Silver J, Winchester RJ, Gregersen PK (1990) Further DNA sequence microheterogeneity of the HLA-DR4/Dw13 haplotype group: importance of amino acid position 86 of the DRβ1 chain for the T cell recognition. Hum Immunol 27: 378–389CrossRefPubMedGoogle Scholar
  24. 24.
    Nepom GT, Seyfried CE, Holbeck SL, Wilske KR, Nepom BS (1986) Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis. Lancet II: 1002–1005Google Scholar
  25. 25.
    Nepom GT, Hansen J, Nepom B (1986) The molecular basis for HLA class II associations with rheumatoid arthritis. J Clin Immunol 7: 1–7Google Scholar
  26. 26.
    Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS (1989) HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32: 15–21PubMedGoogle Scholar
  27. 27.
    Young A, Jaraquemada D, Awad J, Festenstein H, Corbett M, Hay FC, Roitt IM (1984) Association of HLA-DR4/Dw4 and DR2/Dw2 with ratiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities. Arthritis Rheum 27: 20–25PubMedGoogle Scholar
  28. 28.
    Zoschke D, Segall M (1986) Dw subtypes of DR4 in rheumatoid arthritis: evidence for a preferential association with Dw4. Hum Immunol 15: 118–124CrossRefPubMedGoogle Scholar
  29. 29.
    WHO Nomenclature Committee (1988) Nomenclature for factors of the HLA system 1987. Immunobiology 177: 465–476Google Scholar
  30. 30.
    Papasteriades CA, Kappou ID, Skopouli FN, Barla MN, Fostiropoulos GA, Moutsopoulos HM (1985) Lack of HLA-antigen associatiofn in Greek rheumatoid arthritis patients. Rheumatol Int 5: 201–203CrossRefPubMedGoogle Scholar
  31. 31.
    Nunez-Roldan A, Arquer-Zuazua E, Villechonous-Pineda E, de la Prada-Arroyo M (1982) Estudios des los antigenos HLA-DR en la artritis reumatoidea. Rev Esp Reum 9: 9Google Scholar
  32. 32.
    Pareja E, Rodriguez M, Ruiz-Cabello F, de Andres M, Salvatierra D, Garrido F (1983) Artritis reumatoidea y antigenos HLA-DR, M y MT en el Sur des Espana. Immunologia 2: 176Google Scholar
  33. 33.
    Ferraccioli G, Savi M (1988) Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy. J Rheumatol 15: 51–53PubMedGoogle Scholar
  34. 34.
    Jajic Z, Jajic I (1988) Anigens of HLA-DR locus in rheumatoid arthritis. Br J Rheumatol [Suppl 2] 27: 139–140PubMedGoogle Scholar
  35. 35.
    Galeazzi M, Sebastiani GD, Cappellacci S, Lulli P, Mazzilli MC, Tosi R, Tanigaki N (1989) HLA-DR association in rheumatoid arthritis and the shared epitope hypothesis. Arthritis Rheum 32: 663–664PubMedGoogle Scholar
  36. 36.
    Christiansen FT, Kelly H, Dawkins RL (1984) Rheumatoid arthritis. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing 1984. Springer, Berlin Heidelberg New York, pp 378–387Google Scholar
  37. 37.
    Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E (1982) Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis 41: 403–404PubMedGoogle Scholar
  38. 38.
    Brautbar C, Naparstek Y, Yaron M, Amar A, Ehrenfeld M, Eliakim M, Bentwich Z, Cohen T, Korman SH, Albert ED (1986) Immunogenetics of rheumatoid arthritis in Israel. Tissue Antigens 28: 8–14PubMedGoogle Scholar
  39. 39.
    Mehra NK, Kaul R, Taneja V, Chaudhuri TK, Jhinghan B, Malaviya AN (1988) HLA-linked susceptibility to rheumatoid arthritis in north India. Tissue Antigens 31: 220–223PubMedGoogle Scholar
  40. 40.
    Nichol FE, Woodrow JC (1981) HLA-DR antigens in Indian patients with rheumatoid arthritis. Lancet I: 220–221Google Scholar
  41. 41.
    Woodrow JC (1982) Rheumatoid arthritis in British and Asian Indian populations. In: Dawkins RL, Christiansen FT, Zilko PJ (eds) Immunogenetics in rheumatology. Excerpta Medica, Amsterdam Oxford Princeton, pp 92–94Google Scholar
  42. 42.
    Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30: 1205–1213PubMedGoogle Scholar
  43. 43.
    Winchester RJ, Gregersen PK (1988) The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis. Springer Semin Immunopathol 10: 119–139CrossRefPubMedGoogle Scholar
  44. 44.
    Merryman PF, Crapper RM, Lee S, Gregersen PK, Winchester RJ (1989) Class II major histocompatibility complex gene sequences in rheumatoid arthritis. Arthritis Rheum 32: 251–258PubMedGoogle Scholar
  45. 45.
    Carpenter AB, Kahl LE, Bartkowiak CD, Duquesnoy RJ, Eisenbeis CH (1988) Adult rheumatoid arthritis is associated with MC1, a new HLA-D encoded determinant. J Rheumatol 15: 395–399PubMedGoogle Scholar
  46. 46.
    Alarcon GS, Koopman WJ, Acton RT, Barger BO (1982) Seronegative rheumatoid arthritis: a distinct immunogenetic disease? Arthritis Rheum 25: 502–507PubMedGoogle Scholar
  47. 47.
    Bardin T, Legrand L, Naveau B, Marcelli-Barge A, Debeyre N, Lathrop GM, Poirier JC, Schmid M, Ryckewaert A, Dryll A (1985) HLA antigens and seronegative rheumatoid arthritis. Ann Rheum Dis 44: 50–53PubMedGoogle Scholar
  48. 48.
    Masi A, Feigenbaum S (1983) Seronegative rheumatoid arthritis: Fact or fiction? Arch Intern Med 143: 2167–2172CrossRefPubMedGoogle Scholar
  49. 49.
    Gorski J, Eckels DD, Tiercy JM, Ucla C, Mach B (1988) Sequence analysis of the DRw13 beta chain genes: the Dw19 specificity may be encoded by the DR beta III locus. In: Dupont B (ed) Immunobiology of HLA, vol 2. Springer, New York Berlin Heidelberg, pp 220–222Google Scholar
  50. 50.
    Tiercy JM, Gorski J, Bétuel H, Freidel AC, Gebuhrer L, Jeannet M, Mach B (1989) DNA typing of DRw6 subtypes: correlation with DRB1 and DRB3 allelic sequences by hybridization with oligonucleotide probes. Hum Immunol 24: 1–14CrossRefPubMedGoogle Scholar
  51. 51.
    Seyfried CE, Mickelson E, Hansen JA, Nepom GT (1988) A specific nucleotide sequence defines a functional T-cell recognition epitope shared by diverse HLA-DR specificities. Hum Immunol 21: 289–299CrossRefPubMedGoogle Scholar
  52. 52.
    Termijtelen A, van der Elsen P, Koning F, de Koster S, Schroeijers W, Vanderkerckhove B (1989) A novel T-cell-defined HLA-DR polymorphism not predicted from the linear amino acid sequence. Hum Immunol 26: 47–58PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • B. Lang
    • 1
  • I. Melchers
    • 2
  • A. Urlacher
    • 3
  • R. F. Tanzi-Fetta
    • 4
  • S. Kohlbrenner
    • 1
  • M. M. Tongio
    • 3
  • H. H. Peter
    • 1
  1. 1.Department of Rheumatology and Clinical ImmunologyUniversity of Freiburg Medical CenterFreiburgGermany
  2. 2.Clinical Research Unit on RheumatologyUniversity of FreiburgFreiburgGermany
  3. 3.Regional Blood Transfusion Center of StrasbourgStrasbourgFrance
  4. 4.Central Unit for Transfusion MedicineUniversity of FreiburgFreiburgGermany

Personalised recommendations